Latest
Hot
Unlock Pro Investors’ Money-Making Secrets
Join Futubull Community! Now Connect Directly with Top Investors & Public Company Executives
複宏漢霖赴港IPO，你是否看好？
據報導，複巨集漢霖將於9月12日起招股，9月25日港交所掛牌上市。發行區間為49.6-57.8港元，最多集資43億港元。
複宏漢霖為複星醫藥子公司，承擔了複星醫藥的生物製藥業務，至今仍未有盈利。對於此次赴港上市，你怎麼看？
據報導，複巨集漢霖將於9月12日起招股，9月25日港交所掛牌上市。發行區間為49.6-57.8港元，最多集資43億港元。
複宏漢霖為複星醫藥子公司，承擔了複星醫藥的生物製藥業務，至今仍未有盈利。對於此次赴港上市，你怎麼看？
複宏漢霖為複星醫藥子公司，承擔了複星醫藥的生物製藥業務，至今仍未有盈利。對於此次赴港上市，你怎麼看？
Views
6681
Posts
20
Follow
Join topic
Similar Topics
More
- 2026 IPO bonanza! Over 90% of new stocks rose on their debut!59.2M Views · 16K Posts
- Xuanzhu Biotech opened more than 150% higher on its first day. Would you still consider investing?1.1M Views · 333 Posts
- Is the Gray Market Surge Just the Beginning? GenFleet Therapeutics Soars Over 140% on Debut!1.3M Views · 510 Posts
- Zijin Mining and XPL Soar on Debut! Is It Too Late to Buy In?9.3M Views · 1417 Posts
- Dahon Tech's stock opened 36% higher on its first day. Should we take profits or double down?1.3M Views · 199 Posts